SS Innovations International (SSII) AI Stock Analysis

• Market Cap: $1.08B
• Dividend Yield: N/A
• Average Volume (3M): 48.55K
• Price to Earnings (P/E): ―
• Beta (1Y): 9.11
• Revenue Growth: 135.60%
• EPS Growth: 66.47%
• Country: US
• Employees: 378
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): N/A
• Shares Outstanding: 193,588,410
• 10 Day Avg. Volume: 53,387
• 30 Day Avg. Volume: 48,553
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: 1.05
• Enterprise Value/Revenue: 61.10
• Enterprise Value/Gross Profit: 183.86
• Enterprise Value/Ebitda: -58.22
• 1Y Price Target: $6.00
• Price Target Upside: 7.91% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 49 Neutral
• Price Target: $6.00 ▲(7.91% Upside)

SS Innovations International's overall stock score is primarily influenced by its strong corporate events, which highlight significant technological advancements and market potential. However, financial performance challenges, particularly in profitability and cash flow management, along with a weak valuation, weigh down the score. Technical analysis suggests a bearish trend, further impacting the overall assessment.

SS Innovations International Business Overview & Revenue Model

Company Description

SS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room. The company is based in Fort Lauderdale, Florida.

How the Company Makes Money

SS Innovations International generates revenue through multiple streams, primarily by offering software licensing and subscription-based services for its proprietary technology solutions. The company also earns income from consulting services, where it assists clients in customizing and implementing its products to meet specific business needs. Additionally, SSII engages in strategic partnerships with other technology firms and industry leaders, allowing it to expand its reach and enhance its offerings. Revenue is further supplemented by hardware sales, particularly in the IoT segment, where the company provides devices that integrate with its software solutions. Furthermore, SSII may benefit from maintenance contracts and ongoing support services, ensuring a steady income from existing clients.

SS Innovations International Financial Statement Overview

Summary

SS Innovations International shows strong revenue growth but faces significant challenges in profitability and cash flow generation. The balance sheet is improving, with a manageable debt-to-equity ratio and positive equity, but high liabilities remain a concern.

Income Statement

The income statement shows a significant challenge in profitability with negative net income and EBIT margins in the TTM period. Revenue growth is strong, particularly from 2021 to 2023, but the inability to convert this into profitability is concerning. The gross profit margin is positive but overshadowed by high operating costs leading to negative EBITDA and net profit margins.

Balance Sheet

The balance sheet reflects a moderate financial position with an improving equity situation. The debt-to-equity ratio is manageable, and equity has turned positive compared to previous years, indicating stabilization. However, the company still shows a significant amount of total liabilities which may present a risk if not managed properly.

Cash Flow

Cash flow analysis indicates challenges in generating positive operating and free cash flow. There is a consistent negative free cash flow, which may hinder financial flexibility. The operating cash flow to net income ratio suggests inefficiencies in converting revenue to cash. Positive financing activities show reliance on external funding.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	18.54M	20.65M	5.88M	1.46M	0.00	0.00
Gross Profit	6.16M	8.45M	713.45K	489.59K	-18.79K	-37.43K
EBITDA	-19.45M	-17.74M	-20.26M	-5.31M	-1.47M	-1.09M
Net Income	-22.18M	-19.15M	-20.94M	-5.60M	-1.48M	-1.12M
Balance Sheet
Total Assets	63.46M	42.39M	25.48M	8.68M	428.61K	317.87K
Cash, Cash Equivalents and Short-Term Investments	15.87M	466.50K	7.03M	1.57M	405.77K	160.71K
Total Debt	10.45M	18.20M	8.22M	10.24M	145.00K	195.00K
Total Liabilities	22.90M	28.93M	11.18M	11.14M	287.28K	1.19M
Stockholders Equity	40.55M	13.46M	14.30M	-2.46M	141.33K	-869.05K
Cash Flow
Free Cash Flow	-17.16M	-10.16M	-16.34M	-5.78M	-363.03K	-94.54K
Operating Cash Flow	-16.94M	-9.50M	-13.57M	-5.56M	-363.03K	-90.54K
Investing Cash Flow	2.67M	-661.48K	-2.30M	-2.74M	38.15K	-44.00K
Financing Cash Flow	29.09M	9.43M	16.73M	9.29M	569.95K	266.77K

SS Innovations International Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 5.56
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SSII, the sentiment is Negative. The current price of 5.56 is below the 20-day moving average (MA) of 6.13, below the 50-day MA of 6.63, and below the 200-day MA of 7.63, indicating a bearish trend. The MACD of -0.28 indicates Positive momentum. The RSI at 41.70 is Neutral, neither overbought nor oversold. The STOCH value of 41.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SSII.

SS Innovations International Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CNMD	74 Outperform	1.42B	12.99	10.99%	1.74%	4.02%	11.32%
AORT	55 Neutral	1.94B	-95.53	-4.27%	―	7.44%	-109.83%
SSII	49 Neutral	$1.08B	―	-39.11%	―	135.60%	66.47%
TNDM	49 Neutral	810.83M	-3.88	-154.15%	―	25.84%	-47.67%
ESTA	48 Neutral	1.13B	-12.78	-388.86%	―	17.22%	1.65%
IART	47 Neutral	1.03B	-2.02	-48.20%	―	3.53%	-2309.98%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

SS Innovations International Corporate Events

SS Innovations Achieves Milestone with First Robotic Telesurgery

On September 9, 2025, SS Innovations International announced the successful completion of the first robotic telesurgery performed from its MantraM mobile robotic telesurgery unit. This milestone, achieved by Dr. Priya Bhave Chittawar, involved a complex hysterectomy conducted remotely in Bhopal, India, highlighting the company’s mission to provide advanced surgical care to underserved populations. The MantraM bus tour, launched in July 2025 across India, aims to demonstrate the capabilities of SS Innovations’ mobile unit and SSi Mantra system, focusing on hospitals and medical institutions in underserved communities.

SS Innovations Reports Record Q2 2025 Revenue Growth

On August 7, 2025, SS Innovations International reported a significant increase in revenue and gross profit for the second quarter of 2025, driven by higher sales of the SSi Mantra 3 robotic system. The company achieved record quarterly revenue of $10 million, a 121.8% increase from the previous year, and gross profit more than tripled due to expanded gross margins. The company also highlighted several pioneering achievements in robotic surgery, including the world’s first robotic telesurgery for weight loss and intercontinental robotic cardiac telesurgery. SS Innovations’ uplisting to Nasdaq and upcoming regulatory submissions are expected to support its global expansion and continued growth.

SS Innovations CFO Arvind Palaniappan Steps Down

On July 23, 2025, Arvind Palaniappan stepped down as the Interim Chief Financial Officer of SS Innovations International. The company is currently searching for a permanent successor, with Dr. Vishwajyoti P. Srivastava, CEO of Asia Pacific, temporarily taking on the CFO responsibilities, indicating a strategic transition phase for the company.

SS Innovations Completes First Intercontinental Robotic Surgery

On July 19, 2025, SS Innovations International achieved a milestone by completing the world’s first intercontinental robotic cardiac telesurgery. Dr. Sudhir Srivastava conducted the surgery from Strasbourg, France, to Indore, India, using the SSi Mantra 3 system, demonstrating its advanced capabilities and potential to democratize global cardiac care. This event highlights the company’s innovative approach to overcoming traditional surgical barriers and its commitment to improving medical standards worldwide.

SS Innovations Expands Global Reach with Robotic Systems

On July 15, 2025, SS Innovations International announced the installation of over 100 SSi Mantra surgical robotic systems across India and six other countries, with more than 5,000 surgeries performed using the system, including 240 cardiac surgeries and 32 telesurgeries. This milestone reflects the growing demand for the SSi Mantra, attributed to its innovative features and cost-effectiveness, and marks a significant step in the company’s goal to democratize access to robotic surgery. The company also plans to seek regulatory approvals in the U.S. and Europe to further expand its market reach.

SS Innovations Completes First Robotic Telesurgery

On July 10, 2025, SS Innovations International announced the successful completion of the world’s first robotic telesurgery for weight loss using their SSi Mantra 3 surgical robotic system. This groundbreaking bariatric telesurgery was conducted over a distance of 560 miles between Gurugram and Indore, India, with Dr. Mohit Bhandari leading the procedure remotely. The surgery demonstrated zero perceptible lag and flawless precision, setting a new standard for remote surgical capabilities. This achievement underscores SS Innovations’ commitment to democratizing robotic surgery by bridging healthcare gaps and providing advanced surgical care to remote regions, thereby revolutionizing healthcare access and equity.

SS Innovations Completes First Robotic Cardiac Surgery

On June 8, 2025, SS Innovations International announced the successful completion of the first robotic cardiac surgery in the Americas and Western Hemisphere using its SSi Mantra 3 surgical robotic system at Interhospital in Guayaquil, Ecuador. This milestone, achieved by Dr. Juan Zuniga, highlights the system’s capabilities in performing minimally invasive procedures with precision, potentially enhancing recovery times and reducing complications, thus strengthening SS Innovations’ position in the surgical robotics industry.